ArticleFrontiers in medicine2026
Photobleaching-based autofluorescence mapping reveals distinct patterns in sporadic basal cell carcinoma, nevoid basal cell carcinoma syndrome-associated basal cell carcinoma and squamous cell carcinoma.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Real-time LC-OCT monitoring of scalp hypertrophic actinic keratosis clearance following cryotherapy, laser, and 5-fluorouracil therapy.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Autofluorescence (AF) imaging is a promising non-invasive tool for skin cancer diagnostics. However, AF intensity alone often fails to reliably delineate tumor boundaries due to strong influence from melanin, keratin, vasculature, and surface scattering. AF photobleaching kinetics provide an additional functional contrast linked to endogenous fluorophore content and environment microstructure, but their diagnostic potential in clinical skin cancer imaging remains underexplored. Methods: To investigate the photobleaching phenomenon, we analyzed AF and photobleaching behavior in 84 histologically confirmed lesions, including 53 sporadic basal cell carcinomas (BCC), 25 BCCs associated with nevoid basal cell carcinoma syndrome (NBCCS, also known as Gorlin syndrome), and 6 squamous cell carcinomas (SCC). Continuous narrow band LED 405 nm excitation for 20 s enabled pixel-wise fitting of exponential decay curves, generating photobleaching parameter maps describing bleaching amplitude (A), decay constant (τ), and residual component (C). Results: Across all tumor types, lesions consistently exhibited lower initial AF, reduced photobleaching amplitude, and faster τ compared to surrounding skin. A key qualitative finding was a systematic mismatch between lesion boundaries seen in AF intensity versus boundaries revealed by A and τ maps, suggesting that photobleaching parameters capture deeper or structurally distinct tissue alterations not visible in steady-state AF emission imaging. NBCCS-associated BCCs showed more homogeneous A/τ patterns than sporadic tumors, while SCC lesions demonstrated coarse, irregular τ distributions distinct from BCC. Discussion: These observations indicate that photobleaching kinetics provide biologically meaningful contrast and may improve non-invasive tumor characterization, with potential relevance for early diagnosis and surgical margin assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.